Compare PUBM & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PUBM | CYRX |
|---|---|---|
| Founded | 2006 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 847.2M | 883.3M |
| IPO Year | 2020 | 2008 |
| Metric | PUBM | CYRX |
|---|---|---|
| Price | $16.03 | $17.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $21.00 | $19.78 |
| AVG Volume (30 Days) | 495.5K | ★ 659.7K |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $282,926,000.00 | $176,177,000.00 |
| Revenue This Year | $9.05 | $10.95 |
| Revenue Next Year | $8.32 | $10.11 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.15 | $7.61 |
| 52 Week High | $19.30 | $18.88 |
| Indicator | PUBM | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.62 | 48.47 |
| Support Level | $16.02 | $14.55 |
| Resistance Level | $18.16 | $18.17 |
| Average True Range (ATR) | 0.79 | 0.73 |
| MACD | -0.19 | 0.01 |
| Stochastic Oscillator | 4.03 | 42.71 |
PubMatic Inc is is an independent, artificial intelligence-powered advertising technology company that delivers digital advertising performance. Its integrated technology platform connects buyers, publishers, data providers, and commerce media networks on a single, unified platform, to deliver advertising performance, control, transparency and efficiency. Its platform empowers the world's digital content creators (publishers) to maximize monetization of their advertising inventory and audiences and provides control and transparency to buyers, which includes advertisers, agencies, agency trading desks, and demand side platforms (DSPs) (referred as buyers). Geographically, the company generates the majority of its revenue from the United States, followed by EMEA, APAC, and Rest of the World.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.